News & Events

Got news to share? Email cfar@ucsd.edu!

Summer

San Diego Center for AIDS Research Welcomes San Diego State University

La Jolla, CA:  After an eight-month strategic planning process led by Dr. Eileen Pitpitan, the San Diego Center for AIDS Research (SD CFAR) welcomed San Diego State University (SDSU) as a new member institution in June 2020. 

SDSU serves as the academic home to many behavioral, prevention and intervention scientists who conduct high-priority, innovative HIV research. Their HIV-related scientific inquiries address such topics as disparities in the HIV prevention and care continuum, substance use and other co-occurring conditions, and community-based participatory research.

See bulletin post here


Funding for Fellows: Next Generation Grants

SD CFAR’s Next Generation grants are designed for postdoctoral fellows supported by T32, D43, and R25 awards. These grants provide critical funds to help fellows collect and analyze data in support of their CDA applications. Up to $10,000 in direct costs may be requested for a one-year Next Generation grant. View all of the details and download an application form here.



Notice of Intent to Publish - COVID-19 testing in vulnerable and underserved populations

NIH issued a Notice of Intent to Publish (NOITP) four Funding Opportunity Announcements as part of the Rapid Acceleration of Diagnostics for Underserved Populations (RADx-UP) initiative, a $500 million initiative to reduce COVID-19 associated morbidity and mortality disparities for vulnerable and underserved populations that are disproportionately affected by COVID-19.

 

The NOITP is here: https://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-112.html.

 

The FOAs, in which NIAID will be participating, will include three Notices of Special Interest to solicit community-engaged research to understand COVID-19 disparities and increase access to and effectiveness of diagnostic testing interventions among underserved and vulnerable populations and to understand the social, ethical, and behavioral implications of testing in these populations. An RFA to support a Coordination and Data Collection Center (CDCC) will also be announced.

 

In particular, CFAR investigators may be interested in the following NOSI:

 

To solicit emergency competitive revision applications to existing awards for large consortia, multi-site trials, centers and other current networks that have adequate capacity, infrastructure, and established community-engaged relationships to support large-scale testing interventions or have the capacity to ramp up quickly to reach underserved or vulnerable populations.

 

The FOAs are expected to be published in early June. Applications will be accepted through August 2020 for FY20 funding.


Report Out Session of the HIV-Related Intersectional Stigma Research Advances and Opportunities Workshop

Join the NIH Office of AIDS Research and the NIMH Division of AIDS Research for a discussion about the outcomes of recent meetings of four workgroups focused on HIV-related intersectional stigma research advances and opportunities on September 18, 2020 at 8:30am – 11:30am PST (11:30 am-2:30 pm ET). The goal of this virtual workshop is to advance HIV prevention and treatment science, inform the Ending the HIV Epidemic (EHE) initiative, and bolster HIV efforts worldwide.

What: Report Out Session of the HIV-Related Intersectional Stigma Research Advances and Opportunities Workshop

When: September 18, 2020, 11:30 a.m.?2:30 p.m. ET (8:30am-11:30am PST)

Who: Sponsored by the National Institutes of Health (NIH) Office of AIDS Research (OAR) and National Institute of Mental Health (NIMH) Division of AIDS Research 



NIH Opportunities

  1. RFA-OD-19-029, The Intersection of Sex and Gender Influences on Health and Disease (R01 Clinical Trial Optional) -https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-19-029.html. The next receipt date is November 25. Invites research applications that examine sex and gender factors and their intersection in understanding health and disease; and research that addresses one of the five objectives from Strategic Goal 1 of the new 2019-2023 Trans-NIH Strategic Plan for Women's Health Research "Advancing Science for the Health of Women."
  2. NOT-OD-20-049, Notice of Special Interest: Administrative Supplements for Research on Sex/Gender Influences (Admin Supp Clinical Trial Optional) https://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-049.html. The next receipt date is January 25, 2021. 1-year supplements limited to $100K direct costs; Supports preclinical and/or clinical research and must include either adding the opposite sex/gender, increasing sample size, or analyzing existing data to investigate the role of sex/gender. Parent grant must have 16 months remaining from the due date.
  3. NOT-OD-20-054 – Administrative Supplements to Promote Research Continuity and Retention of NIH Mentored Career Development (K) Award Recipients and Scholars. 
  4. NOT-OD-20-055 – Administrative Supplement for Continuity of Biomedical and Behavioral Research Among First-Time Recipients of NIH Research Project Grant Awards.

Both (NOT-OD-20-054 and NOT-OD-20-055) are up to $50K and can be used for computational services, supplies, equipment, and additional staff to sustain the research. These are meant to help investigators at critical stages of their career who may need additional support due to critical life events (childbirth or adoption during the parent grant project period; or primary caregiving responsibilities of an ailing spouse, partner, or a member of the immediate family). In circumstances in which the critical life event is pending and is expected to occur during the project period, the supplement period may be submitted in advance of the event. There are no set due dates, but March 5 is the earliest opportunity to submit.


11th International Workshop on HIV & Aging (October 1-2, 2020)

The HIV & Aging Inter-CFAR Working Group is pleased to announce the 11th International Workshop on HIV & Aging in New York on October 1-2, 2020. Virology Education has graciously offered to provide 10 fee waivers for registration for Investigators from CFARs to attend. CFARs may select up to 2 Investigators and submit their names to David Johnson, dxj249@med.miami.edu. Registration fee waivers will be available on a first come - first served basis. An announcement will follow once all slots have been filled. A code will be sent to those receiving the fee waiver. This is a great opportunity for CFARs with HIV and Aging SWGs but is open to all CFARs.



San Diego Center for AIDS Research Welcomes San Diego State University

After an eight-month strategic planning process led by Dr. Eileen Pitpitan, the San Diego Center for AIDS Research (SD CFAR) welcomed San Diego State University (SDSU) as a new member institution in June 2020. SDSU serves as the academic home to many behavioral, prevention and intervention scientists who conduct high-priority, innovative HIV research. Their HIV-related scientific inquiries address such topics as disparities in the HIV prevention and care continuum, substance use and other co-occurring conditions, and community- based participatory research. SD CFAR has strong track record of synergizing high-impact, multidisciplinary HIV/AIDS research that emphasizes the Center’s four priority research areas: optimizing HIV care, relieving health disparities, finding a cure, and developing vaccines. SDSU will engage in these activities in support of the overall mission of SD CFAR, including fostering new collaborations between individual researchers and SD CFAR service cores; expanding the use of SD CFAR service cores and resources; promoting funding collaborations and publishing opportunities; and facilitating the professional development of junior faculty and trainees. SDSU faculty will also serve as key members of the SD CFAR EHE Scientific Working Group.


2 New NIDDK RFAs - Comorbidities and Cure

NIDDK has recently published two RFAs below

  • RFA-DK-20-022, “Toward ElucidAting MechanismS of HIV Pathogenesis within the Mission of the NIDDK (Pathogenesis TEAMS) (R01 Clinical Trial Optional)”
  • RFA-DK-20-023, “Toward ElucidAting MechanismS Contributing to HIV Reservoirs in NIDDK-relevant Tissues (Cure TEAMS) (R01 Clinical Trial Optional)”

LOI Due dates for both RFAs: February 3, 2021 and October 17, 2021

Please note that each RFA requires an MPI structure. At least one PI must have expertise in HIV science and at least one PI must have expertise in physiology, pathophysiology, pathobiology, or metabolism.



HIV & Aging Southern California Conference

APLA Health with our partner, The UCLA Pacific AIDS Education Training Center, invite you to participate in the first HIV & Aging Southern California Conference on September 23 & 25. It is estimated that by 2030, 70% of people living with HIV will be 50 years or older.  However, there are many questions raised by significant improvements in life expectancy due to effective treatment. Central among these are what are the experiences of people living with HIV who are getting older and are the existing senior services meeting the multiple needs of older adults living with HIV? Our subject matter experts will address these concerns and your questions. 


NCI FOA (RFA-CA-20-046): Investigation of the Transmission of Kaposi Sarcoma-Associated Herpesvirus (KSHV) (R01 Clinical Trial Optional)

Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) intends to advance our understanding of: the modes of transmission of Kaposi sarcoma-associated herpesvirus (KSHV), also called human herpesvirus-8 (HHV-8); the biology of the initial steps of infection; and the risk factors for infection. Such studies should inform and advance efforts to reduce or eliminate KSHV transmission and thus prevent Kaposi sarcoma (KS), KSHV-associated multicentric Castleman disease (MCD), primary effusion lymphoma (PEL), and other KSHV-induced diseases in populations living with HIV or at high risk of HIV infection.

Application Due Date: December 15, 2020; December 14, 2021

LOI Due date: 30 days prior to the application due date







To view previous News & Events, click here